There is evidence that PAI-2 may block uPA-mediated proteolysis and is inversely correlated with tumour progression of nonsmall cell lung carcinomas and neuroendocrine lung tumours (Robert et al, 1999) and breast cancer (Borstnar et al, 2002). The gene discussed is SERPINB2; the disease is breast carcinoma.